Our solutions drive results that you can verify. We assess your market position, create new strategy, and execute quickly. Our focus is value - creating improved economics for you and your clients that drive growth. 



The drug market is changing quickly. Growth requires a competitive edge across the drug supply chain. When you need new models or disruption, XIL specializes in rapid impact. Strategy & economics that change the way you compete.


We work across the drug benefit landscape with Fortune 500 companies that define the market: retail pharmacies, pharmacy benefit managers, specialty/biotech drug manufacturers, wholesalers, generic companies, and brand drug manufacturers.





At XIL, we work with c-suite executives driven to compete and steer the market toward their vision. Whether it's to fund earnings, expand markets, or retain clients - we understand how to win.


Our focus: provider networks, specialty, home infusion, rebates, acquisitions and mergers, client RFPs and pricing, guarantee management, MAC, MAC appeals, analytics and strategy.


“My team has really changed the way they view the market.  In such a short time, we are so much more strategic in our thinking. Thank you so much for your services.”

  -- C-suite executive, Fortune 200 company​​​